Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19–related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Detalles Bibliográficos
Autores principales: Dogan, Lerzan, Kaya, Dilaver, Sarikaya, Tugce, Zengin, Rehile, Dincer, Alp, Akinci, Ibrahim Ozkan, Afsar, Nazire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204750/
https://www.ncbi.nlm.nih.gov/pubmed/32389697
http://dx.doi.org/10.1016/j.bbi.2020.05.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204750/
https://www.ncbi.nlm.nih.gov/pubmed/32389697
http://dx.doi.org/10.1016/j.bbi.2020.05.022

Ejemplares similares